Literature DB >> 18923749

Genetic polymorphism study of regulatory B cell molecules and cellular immunity function in an adult patient with Common Variable Immunodeficiency.

A Sarantopoulos1, K Tselios, P Skendros, D Bougiouklis, I Theodorou, P Boura.   

Abstract

A 43 year old female patient presented for recurrent bacterial lower respiratory infections. A research for immunodeficiency status revealed total hypogammaglobulinemia, reduced IgG1, IgG2, IgG3 subclass levels, and low number of B lymphocytes (CD19+). Common Variable Immunodeficiency (CVID) 11.2 category was diagnosed according to recent criteria of primary immunodeficiencies (PID). Further immunological study consisting of genetic polymorphism of genes relating to differentiation, activation and function of B cells (ICOS, BAFF receptor BCMA and TACI) was performed, which did not reveal any related mutations. T cell parameters and Th1/Th2 cytokine network did not show any disturbances. It is postulated that probable endstage B cell differentiation defects should be investigated. The patient receives IVIGs replacement thereafter and the rate and severity of infections have significantly improved.

Entities:  

Keywords:  common variable immunodeficiency; gene polymorphism

Year:  2008        PMID: 18923749      PMCID: PMC2504409     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  10 in total

Review 1.  Molecular basis of common variable immunodeficiency.

Authors:  Emanuela Castigli; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2006-04       Impact factor: 10.793

Review 2.  Clinical and laboratory aspects of common variable immunodeficiency.

Authors:  Cristina M Kokron; Paolo R Errante; Myrthes T Barros; Gisele V Baracho; Maristela M Camargo; Jorge Kalil; Luiz V Rizzo
Journal:  An Acad Bras Cienc       Date:  2004-11-16       Impact factor: 1.753

3.  Practice parameter for the diagnosis and management of primary immunodeficiency.

Authors:  Francisco A Bonilla; I Leonard Bernstein; David A Khan; Zuhair K Ballas; Javier Chinen; Michael M Frank; Lisa J Kobrynski; Arnold I Levinson; Bruce Mazer; Robert P Nelson; Jordan S Orange; John M Routes; William T Shearer; Ricardo U Sorensen
Journal:  Ann Allergy Asthma Immunol       Date:  2005-05       Impact factor: 6.347

4.  The European internet-based patient and research database for primary immunodeficiencies: results 2004-06.

Authors:  A-M Eades-Perner; B Gathmann; V Knerr; D Guzman; D Veit; G Kindle; B Grimbacher
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 5.  Regulation of T:B cell interactions by the inducible costimulator molecule: does ICOS "induce" disease?

Authors:  Rebecca A Shilling; Hozefa S Bandukwala; Anne I Sperling
Journal:  Clin Immunol       Date:  2006-06-21       Impact factor: 3.969

6.  Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005.

Authors:  Luigi Notarangelo; Jean-Laurent Casanova; Mary Ellen Conley; Helen Chapel; Alain Fischer; Jennifer Puck; Chaim Roifman; Reinhard Seger; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2006-04       Impact factor: 10.793

Review 7.  Common variable immunodeficiency: the immune system in chaos.

Authors:  Jagadeesh Bayry; Olivier Hermine; David A Webster; Yves Lévy; Srini V Kaveri
Journal:  Trends Mol Med       Date:  2005-08       Impact factor: 11.951

Review 8.  Common variable immunodeficiency: test indications and interpretations.

Authors:  Catherine R Weiler; Jennifer L Bankers-Fulbright
Journal:  Mayo Clin Proc       Date:  2005-09       Impact factor: 7.616

Review 9.  Evaluation of the adult with suspected immunodeficiency.

Authors:  Antoine E Azar; Zuhair K Ballas
Journal:  Am J Med       Date:  2007-09       Impact factor: 4.965

Review 10.  Genetic defects in common variable immunodeficiency.

Authors:  O Kopecký; S Lukesová
Journal:  Int J Immunogenet       Date:  2007-08       Impact factor: 1.466

  10 in total
  1 in total

1.  Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI).

Authors:  Wikke Koopmans; See-Tarn Woon; Anna E S Brooks; P Rod Dunbar; Peter Browett; Rohan Ameratunga
Journal:  J Clin Immunol       Date:  2012-09-15       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.